Journal Article Summary
The article investigates the relationships between changes in ADHD symptoms, functional impairments, and health-related quality of life (HRQoL) in children and adolescents diagnosed with ADHD. Understanding these correlations is important because ADHD affects not only attention and behavior but also various aspects of a child's daily life, including social interactions and academic performance. By examining how treatment impacts these different areas, the study aims to provide insights that could enhance treatment approaches and improve overall patient outcomes.
The researchers conducted post hoc analyses of data from two randomized clinical trials involving children and adolescents with ADHD. They used established measures, including the ADHD Rating Scale IV (ADHD-RS-IV) for symptoms, the Child Health and Illness Profile−Child Edition: Parent Report Form (CHIP-CE:PRF) for HRQoL, and the Weiss Functional Impairment Rating Scale–Parent (WFIRS-P) for functional impairments. The findings indicated moderate correlations between changes in ADHD symptoms and improvements in both functional impairments and HRQoL, suggesting that as ADHD symptoms decrease, there are also improvements in the child's overall functioning and quality of life.
However, the study has limitations, such as the short duration of the trials and the fact that not all measures were included in both studies. This means that while the findings are informative, they may not capture the full picture of long-term treatment effects. Patients and caregivers should discuss these findings with healthcare professionals to understand how ADHD treatment can affect not just symptoms but also daily functioning and quality of life. This conversation can help ensure a comprehensive approach to managing ADHD that considers all aspects of a child's well-being.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Coghill David R., Joseph Alain, Sikirica Vanja, Kosinski Mark, Bliss Caleb, Huss Michael. Correlations Between Clinical Trial Outcomes Based on Symptoms, Functional Impairments, and Quality of Life in Children and Adolescents With ADHD. Journal of Attention Disorders 2017. DOI: 10.1177/1087054717723984. PMID: 28836895. PMCID: PMC6732817.
Featured Pill Pals Product
Atomoxetine 60 mg Capsules --- Generic for Strattera --- Glenmark
Atomoxetine 60 mg Capsules — Generic for Strattera — Glenmark is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
